The soluble receptor for advanced glycation end products is potentially predictive of pulmonary arterial hypertension in systemic sclerosis

被引:4
作者
Atzeni, Isabella M. [1 ]
Al-Adwi, Yehya [1 ]
Doornbos van der Meer, Berber [2 ]
Roozendaal, Caroline [3 ]
Stel, Alja [2 ]
van Goor, Harry [4 ]
Gan, C. Tji [5 ]
Dickinson, Michael [6 ]
Timens, Wim [4 ]
Smit, Andries J. [1 ]
Westra, Johanna [2 ]
Mulder, Douwe J. [1 ]
机构
[1] Univ Groningen, Univ Med Ctr Groningen, Dept Internal Med, Div Vasc Med, Groningen, Netherlands
[2] Univ Groningen, Univ Med Ctr Groningen, Dept Rheumatol & Clin Immunol, Groningen, Netherlands
[3] Univ Groningen, Univ Med Ctr Groningen, Dept Lab Med, Groningen, Netherlands
[4] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Groningen, Netherlands
[5] Univ Groningen, Univ Med Ctr Groningen, Dept Pulm Dis & TB, Groningen, Netherlands
[6] Univ Groningen, Univ Med Ctr Groningen, Dept Cardiol, Groningen, Netherlands
来源
FRONTIERS IN IMMUNOLOGY | 2023年 / 14卷
关键词
PAH; sRAGE; predictability; SSc; scleroderma; ILD; LUNG-DISEASE; RAGE; CLASSIFICATION; PROGRESSION; FIBROSIS; AGE;
D O I
10.3389/fimmu.2023.1189257
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Introduction: Pulmonary arterial hypertension (PAH) and interstitial lung disease (ILD) are the leading causes of death in systemic sclerosis (SSc). Until now, no prospective biomarker to predict new onset of SSc-ILD or SSc-PAH in patients with SSc has reached clinical application. In homeostasis, the receptor for advanced glycation end products (RAGE) is expressed in lung tissue and involved in cell-matrix adhesion, proliferation and migration of alveolar epithelial cells, and remodeling of the pulmonary vasculature. Several studies have shown that sRAGE levels in serum and pulmonary tissue vary according to the type of lung-related complication. Therefore, we investigated levels of soluble RAGE (sRAGE) and its ligand high mobility group box 1 (HMGB1) in SSc and their abilities to predict SSc-related pulmonary complications. Methods: One hundred eighty-eight SSc patients were followed retrospectively for the development of ILD, PAH, and mortality for 8 years. Levels of sRAGE and HMGB1 were measured in serum by ELISA. Kaplan-Meier survival curves were performed to predict lung events and mortality and event rates were compared with a log-rank test. Multiple linear regression analysis was performed to examine the association between sRAGE and important clinical determinants. Results: At baseline, levels of sRAGE were significantly higher in SSc-PAH-patients (median 4099.0 pg/ml [936.3-6365.3], p = 0.011) and lower in SSc-ILD-patients (735.0 pg/ml [IQR 525.5-1988.5], p = 0.001) compared to SSc patients without pulmonary involvement (1444.5 pg/ml [966.8-2276.0]). Levels of HMGB1 were not different between groups. After adjusting for age, gender, ILD, chronic obstructive pulmonary disease, anti-centromere antibodies, the presence of puffy fingers or sclerodactyly, use of immunosuppression, antifibrotic therapy, or glucocorticoids, and use of vasodilators, higher sRAGE levels remained independently associated with PAH. After a median follow-up of 50 months (25-81) of patients without pulmonary involvement, baseline sRAGE levels in the highest quartile were predictive of development of PAH (log-rank p = 0.01) and of PAH-related mortality (p = 0.001). Conclusions: High systemic sRAGE at baseline might be used as a prospective biomarker for patients with SSc at high risk to develop new onset of PAH. Moreover, high sRAGE levels could predict lower survival rates due to PAH in patients with SSc.
引用
收藏
页数:11
相关论文
共 35 条
  • [1] High Mobility Group Box 1 Contributes to the Pathogenesis of Experimental Pulmonary Hypertension via Activation of Toll-like Receptor 4
    Bauer, Eileen M.
    Shapiro, Richard
    Zheng, Han
    Ahmad, Ferhaan
    Ishizawar, David
    Comhair, Suzy A.
    Erzurum, Serpil C.
    Billiar, Timothy R.
    Bauer, Philip M.
    [J]. MOLECULAR MEDICINE, 2012, 18 (12) : 1509 - 1518
  • [2] Identifying early pulmonary arterial hypertension biomarkers in systemic sclerosis: machine learning on proteomics from the DETECT cohort
    Bauer, Yasmina
    de Bernard, Simon
    Hickey, Peter
    Ballard, Karri
    Cruz, Jeremy
    Cornelisse, Peter
    Chadha-Boreham, Harbajan
    Distler, Oliver
    Rosenberg, Daniel
    Doelberg, Martin
    Roux, Sebastien
    Nayler, Oliver
    Lawrie, Allan
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2021, 57 (06)
  • [3] Biomarkers in systemic sclerosis-associated interstitial lung disease: review of the literature
    Bonhomme, Olivier
    Andre, Beatrice
    Gester, Fanny
    de Seny, Dominique
    Moermans, Catherine
    Struman, Ingrid
    Louis, Renaud
    Malaise, Michel
    Guiot, Julien
    [J]. RHEUMATOLOGY, 2019, 58 (09) : 1534 - 1546
  • [4] The Receptor for Advanced Glycation End Products (RAGE) and the Lung
    Buckley, Stephen T.
    Ehrhardt, Carsten
    [J]. JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY, 2010,
  • [5] Soluble Receptor for Advanced Glycation End Products (sRAGE) Is a Sensitive Biomarker in Human Pulmonary Arterial Hypertension
    Diekmann, Franziska
    Chouvarine, Philippe
    Sallmon, Hannes
    Meyer-Kobbe, Louisa
    Kieslich, Moritz
    Plouffe, Brian D.
    Murthy, Shashi K.
    Lichtinghagen, Ralf
    Legchenko, Ekaterina
    Hansmann, Georg
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (16)
  • [6] RAGE, vascular tone and vascular disease
    Farmer, David G. S.
    Kennedy, Simon
    [J]. PHARMACOLOGY & THERAPEUTICS, 2009, 124 (02) : 185 - 194
  • [7] 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS) Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT)
    Galie, Nazzareno
    Humbert, Marc
    Vachiery, Jean-Luc
    Gibbs, Simon
    Lang, Irene
    Torbicki, Adam
    Simonneau, Gerald
    Peacock, Andrew
    Noordegraaf, Anton Vonk
    Beghetti, Maurice
    Ghofrani, Ardeschir
    Gomez Sanchez, Miguel Angel
    Hansmann, Georg
    Klepetko, Walter
    Lancellotti, Patrizio
    Matucci, Marco
    McDonagh, Theresa
    Pierard, Luc A.
    Trindade, Pedro T.
    Zompatori, Maurizio
    Hoeper, Marius
    [J]. EUROPEAN HEART JOURNAL, 2016, 37 (01) : 67 - +
  • [8] Interstitial Lung Disease Associated With Systemic Sclerosis and Idiopathic Pulmonary Fibrosis How Similar and Distinct?
    Herzog, Erica L.
    Mathur, Aditi
    Tager, Andrew M.
    Feghali-Bostwick, Carol
    Schneider, Frank
    Varga, John
    [J]. ARTHRITIS & RHEUMATOLOGY, 2014, 66 (08) : 1967 - 1978
  • [9] Circulating Protein Biomarkers in Systemic Sclerosis Related Pulmonary Arterial Hypertension: A Review of Published Data
    Hickey, Peter M.
    Lawrie, Allan
    Condliffe, Robin
    [J]. FRONTIERS IN MEDICINE, 2018, 5
  • [10] Identification, classification, and expression of RAGE gene splice variants
    Hudson, Barry I.
    Carter, Angela M.
    Harja, Evis
    Kalea, Anastasia Z.
    Arriero, Maria
    Yang, Hojin
    Grant, Peter J.
    Schmidt, Ann Marie
    [J]. FASEB JOURNAL, 2008, 22 (05) : 1572 - 1580